Margit Michelle McGowan DO
Gastrointestinal Cancer, Hematologic Oncology
Assistant Professor of Clinical Medicine, Tulane University School of Medicine, Section of Hematology/Medical Oncology
Join to View Full Profile
1430 Tulane Ave# SL-78New Orleans, LA 70112
Phone+1 504-988-3606
Dr. McGowan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Margit McGowan is an oncologist in New Orleans, LA.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
UMass Chan - BaystateResidency, Internal Medicine, 2002 - 2004
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 2001 - 2002
University of New England College of Osteopathic MedicineClass of 2001
Certifications & Licensure
LA State License 2013 - 2025
MS State License 2019 - 2023
NH State License 2008 - 2014
Awards, Honors, & Recognition
- Teaching Commendations (3) Tulane Medical Center, 2015-2016
- Dartmouth-Hitchcock Medical Center Pilot Grant $50,000, 2011
- Dartmouth-Hitchcock Medical Center Pilot Grant $100,000, 2011
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsCutaneous Metastases from Primary Hepatobiliary Tumors as the First Sign of Tumor Recurrence following Liver Transplantation.Adam Hauch, Joseph F. Buell, Margit M. McGowan, Parisha Bhatia, Eleanor Lewin
Case Reports in Transplantation. 2014-07-10 - 23 citationsA proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissueMargit M. McGowan, Burton L. Eisenberg, Lionel D. Lewis, Heather M. Froehlich, Wendy A. Wells
Breast Cancer Research and Treatment. 2013-02-16 - 29 citationsNeoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinomaJ. M. Pipas, Bassem I. Zaki, Margit M. McGowan, Michael J. Tsapakos, Gregory H. Ripple
Annals of Oncology. 2012-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
